​

iBio (IBIO) Revenue & Revenue Breakdown

OverviewFinancialsChart

iBio Revenue Highlights

Latest Revenue (Y)

$225.00K

0

Main Segment (Y)

Ibio Cdmo

iBio Revenue by Period

iBio Revenue by Year

DateRevenueChange
2024-06-30$225.00K100.00%
2023-06-30--100.00%
2022-06-30$1.88M-20.54%
2021-06-30$2.37M44.75%
2020-06-30$1.64M-18.83%
2019-06-30$2.02M354.50%
2018-06-30$444.00K12.69%
2017-06-30$394.00K-58.44%
2016-06-30$948.00K-48.78%
2015-06-30$1.85M802.93%
2014-06-30$205.00K-79.64%
2013-06-30$1.01M-21.14%
2012-06-30$1.28M145.54%
2011-06-30$520.08K100.00%
2010-06-30--

iBio generated $225.00K in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 11.15% compared to the same period a year ago.

iBio Revenue by Quarter

DateRevenueChange
2025-03-31--100.00%
2024-12-31$200.00K100.00%
2024-09-30--100.00%
2024-06-30$175.00K100.00%
2024-03-31-100.00%
2023-12-31--100.00%
2023-09-30$50.00K100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30--100.00%
2022-06-30$61.00K-96.86%
2022-03-31$1.94M1056.55%
2021-12-31$168.00K-20.38%
2021-09-30$211.00K-57.03%
2021-06-30$491.00K-35.82%
2021-03-31$765.00K8.51%
2020-12-31$705.00K71.95%
2020-09-30$410.00K-63.39%
2020-06-30$1.12M1066.67%
2020-03-31$96.00K-69.43%
2019-12-31$314.00K190.74%
2019-09-30$108.00K-86.42%
2019-06-30$795.00K50.85%
2019-03-31$527.00K-19.05%
2018-12-31$651.00K1346.67%
2018-09-30$45.00K-50.55%
2018-06-30$91.00K16.67%
2018-03-31$78.00K-49.02%
2017-12-31$153.00K25.41%
2017-09-30$122.00K-17.01%
2017-06-30$147.00K297.30%
2017-03-31$37.00K-50.67%
2016-12-31$75.00K-44.44%
2016-09-30$135.00K-50.91%
2016-06-30$275.00K-27.44%
2016-03-31$379.00K182.84%
2015-12-31$134.00K-16.25%
2015-09-30$160.00K-49.37%
2015-06-30$316.00K-9.46%
2015-03-31$349.00K-4.90%
2014-12-31$367.00K-55.19%
2014-09-30$819.00K299.51%
2014-06-30$205.00K100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30--100.00%
2013-06-30$616.81K100.00%
2013-03-31-100.00%
2012-12-31--100.00%
2012-09-30$390.19K11.03%
2012-06-30$351.41K-5.47%
2012-03-31$371.75K58.98%
2011-12-31$233.83K-27.01%
2011-09-30$320.35K-6.90%
2011-06-30$344.08K95.51%
2011-03-31$176.00K100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30--

iBio generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

iBio Revenue Breakdown

iBio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceJun 21Jun 20Jun 19Jun 18
Ibio Cdmo$1.27M$92.00K--
Ibio Inc$1.10M$1.55M$2.02M-
Grant---$44.00K

iBio's latest annual revenue breakdown by segment (product or service), as of Jun 21: Ibio Cdmo (53.71%), and Ibio Inc (46.29%).

Quarterly Revenue by Product

Product/ServiceMar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Mar 18
Ibio Cdmo$143.00K$168.00K$127.00K$491.00K$65.00K$515.00K$203.00K$-1.00K$21.00K$72.00K$161.00K-----
Ibio Inc$1.80M-$84.00K$1.00K$700.00K$190.00K$207.00K$1.12M$75.00K$242.00K$108.00K$795.00K$527.00K$651.00K$45.00K$78.00K
iBio CDMO----------------

iBio's latest quarterly revenue breakdown by segment (product or service), as of Mar 22: Ibio Inc (92.64%), and Ibio Cdmo (7.36%).

iBio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BCRXBioCryst Pharmaceuticals$450.71M$145.53M
ADMAADMA Biologics$426.45M$117.55M
VXRTVaxart$28.70M$15.19M
JAGXJaguar Health$11.56M$2.17M
TNXPTonix Pharmaceuticals$10.09M$2.43M
OCGNOcugen$4.05M$764.00K
IBIOiBio$225.00K-
SONNSonnet BioTherapeutics$147.81K-
GOVXGeoVax Labs--
PALIPalisade Bio--

IBIO Revenue FAQ

What is iBio’s yearly revenue?

iBio's yearly revenue for 2024 was $225K, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. IBIO's yearly revenue for 2022 was $1.88M, representing a decrease of -20.54% compared to 2021.

What is iBio’s quarterly revenue?

iBio's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $200K, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). IBIO's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a -100.00% decrease year-over-year (Q1 2024).

What is iBio’s revenue growth rate?

iBio's revenue growth rate for the last 3 years (2022-2024) was -88.06%, and for the last 5 years (2020-2024) was -86.26%.

What are iBio’s revenue streams?

iBio's revenue streams in n 21 are Ibio Cdmo, and Ibio Inc. Ibio Cdmo generated $1.27M in revenue, accounting 53.71% of the company's total revenue, up 1284.78% year-over-year. Ibio Inc generated $1.1M in revenue, accounting 46.29% of the company's total revenue, down -28.98% year-over-year.

What is iBio’s main source of revenue?

For the fiscal year ending Jun 21, the largest source of revenue of iBio was Ibio Cdmo. This segment made a revenue of $1.27M, representing 53.71% of the company's total revenue.